Literature DB >> 22036195

Evidence for functional trace amine associated receptor-1 in normal and malignant B cells.

Agata M Wasik1, Mark J Millan, Thomas Scanlan, Nicholas M Barnes, John Gordon.   

Abstract

Following the observation that dopaminergic components are present in normal and malignant B cells, we now provide evidence that they additionally express the functionally related trace amine-associated receptor-1 (TAAR1). Immunodetectable TAAR1 was found in lines derived from a broad range of B-cell malignancy; and in tonsillar B cells, particularly when activated. L3055 Burkitt's lymphoma cells were shown to respond to prototypical TAAR1 agonists in cytotoxicity assays with features of apoptotic death evident; normal B cells were somewhat less sensitive to the agonists. These data raise the possibility that TAAR1 may have therapeutic relevance to leukemia, lymphoma, and wider B-cell pathologies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036195      PMCID: PMC5293406          DOI: 10.1016/j.leukres.2011.10.002

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies.

Authors:  Anita Chamba; Michelle J Holder; Ruth F Jarrett; Lesley Shield; Kai M Toellner; Mark T Drayson; Nicholas M Barnes; John Gordon
Journal:  Leuk Res       Date:  2010-04-02       Impact factor: 3.156

2.  The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.

Authors:  Elizabeth J Meredith; Michelle J Holder; Anita Chamba; Anita Challa; Adrian Drake-Lee; Christopher M Bunce; Mark T Drayson; Geoffrey Pilkington; Randy D Blakely; Martin J S Dyer; Nicholas M Barnes; John Gordon
Journal:  FASEB J       Date:  2005-05-03       Impact factor: 5.191

3.  Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.

Authors:  Zhihua Xie; Susan V Westmoreland; Mary E Bahn; Guo-Lin Chen; Hong Yang; Eric J Vallender; Wei-Dong Yao; Bertha K Madras; Gregory M Miller
Journal:  J Pharmacol Exp Ther       Date:  2007-01-18       Impact factor: 4.030

Review 4.  Trace amine-associated receptors as emerging therapeutic targets.

Authors:  Tatyana D Sotnikova; Marc G Caron; Raul R Gainetdinov
Journal:  Mol Pharmacol       Date:  2009-04-23       Impact factor: 4.436

Review 5.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

6.  Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes.

Authors:  Daniel A Nelson; Melanie D Tolbert; Sam J Singh; Kenneth L Bost
Journal:  J Neuroimmunol       Date:  2007-09-27       Impact factor: 3.478

Review 7.  Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations.

Authors:  Nicholas M Barnes; John Gordon
Journal:  Semin Cancer Biol       Date:  2007-12-08       Impact factor: 15.707

  7 in total
  14 in total

Review 1.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

Review 2.  Commonalities and Distinctions Among Mechanisms of Addiction to Alcohol and Other Drugs.

Authors:  Angela R Ozburn; Aaron J Janowsky; John C Crabbe
Journal:  Alcohol Clin Exp Res       Date:  2015-10       Impact factor: 3.455

3.  Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2.

Authors:  Xiao Shi; Tracy L Swanson; Nicholas B Miner; Amy J Eshleman; Aaron Janowsky
Journal:  Mol Pharmacol       Date:  2019-08-13       Impact factor: 4.436

Review 4.  Neuroimmune basis of methamphetamine toxicity.

Authors:  Jennifer M Loftis; Aaron Janowsky
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

5.  Methamphetamine induces trace amine-associated receptor 1 (TAAR1) expression in human T lymphocytes: role in immunomodulation.

Authors:  Uma Sriram; Jonathan M Cenna; Bijayesh Haldar; Nicole C Fernandes; Roshanak Razmpour; Shongshan Fan; Servio H Ramirez; Raghava Potula
Journal:  J Leukoc Biol       Date:  2015-08-24       Impact factor: 4.962

6.  "TAARgeting Addiction"--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference.

Authors:  David K Grandy; Gregory M Miller; Jun-Xu Li
Journal:  Drug Alcohol Depend       Date:  2015-11-22       Impact factor: 4.492

7.  Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5.

Authors:  Juliane Dinter; Jessica Mühlhaus; Carolin Leonie Wienchol; Chun-Xia Yi; Daniela Nürnberg; Silke Morin; Annette Grüters; Josef Köhrle; Torsten Schöneberg; Matthias Tschöp; Heiko Krude; Gunnar Kleinau; Heike Biebermann
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

8.  Analysis of human TAAR8 and murine Taar8b mediated signaling pathways and expression profile.

Authors:  Jessica Mühlhaus; Juliane Dinter; Daniela Nürnberg; Maren Rehders; Maren Depke; Janine Golchert; Georg Homuth; Chun-Xia Yi; Silke Morin; Josef Köhrle; Klaudia Brix; Matthias Tschöp; Gunnar Kleinau; Heike Biebermann
Journal:  Int J Mol Sci       Date:  2014-11-10       Impact factor: 5.923

9.  Trace Amine-Associated Receptors as Novel Therapeutic Targets for Immunomodulatory Disorders.

Authors:  Sherri L Christian; Mark D Berry
Journal:  Front Pharmacol       Date:  2018-07-02       Impact factor: 5.810

Review 10.  Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?

Authors:  Jesús Cosín-Roger; Dolores Ortiz-Masia; Maria Dolores Barrachina; Sara Calatayud
Journal:  Cells       Date:  2020-10-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.